SCHEMBL31405167

SCHEMBL31405167

CC(C)(C)N(CC(=O)O)c1cc(-c2cn[nH]c2)nc2c(Cl)c(Cl)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 1/20 0.34
▸ ACACA Q13085 1/20 0.34
▸ FGFR1 P11362 1/20 0.33
▸ FGFR2 P21802 1/20 0.33
▸ FGFR4 P22455 1/20 0.33
▸ FGFR3 P22607 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ IRAK4 Q9NWZ3 1/20 0.33
▸ PPARA Q07869 1/20 0.33
▸ ROCK2 O75116 9/20 0.32
▸ ROCK1 Q13464 8/20 0.32
▸ GRM2 Q14416 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ DYRK1A Q13627 2/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31296605 0.82 KDM4E (0.34) ALDH1A1KMT2AKDM4EPKMHTT
SCHEMBL31405145 0.80 ALDH1A1 (0.34) PPARAALDH1A1KMT2AKDM4EPKM
SCHEMBL26998248 0.77 FGFR1 (0.42) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL26999128 0.76 MCL1 (0.37) IRAK4PPARAROCK2ROCK1
SCHEMBL25423523 0.75 IRAK4 (0.40) IRAK4PPARAROCK2ROCK1
SCHEMBL25424986 0.74 AKT2 (0.39) IRAK4GRM2CLK1CLK2HIPK1
SCHEMBL26725208 0.72 ACACB (0.39) ACACBACACAIRAK4ROCK2ROCK1
SCHEMBL31405130 0.72 KDM4E (0.40) PPARAMEN1ALDH1A1KMT2AKDM4E
SCHEMBL26998239 0.71 IRAK4 (0.39) IRAK4PPARAROCK2ROCK1DYRK1A
SCHEMBL26998240 0.71 IRAK4 (0.39) IRAK4PPARAROCK2ROCK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250115579-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-04-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250115579-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, GLS2, GLS ACACB 3291/4885ACACA 3213/4885FGFR1 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback